Phase 2b study of LY3009104 in Rheumatoid Arthritis

• Research type

  Research Study

• Full title

  A Randomised, Double-Blind, Placebo-Controlled, Dose-Ranging, Parallel-Group, Phase 2b Study of LY3009104 in Patients with Active Rheumatoid Arthritis on Background Methotrexate Therapy

• IRAS ID

  64009

• Contact name

  Claire Smith

• Contact email

  claire.smith@parexel.com

• Sponsor organisation

  Eli Lilly and Company

• Eudract number

  2010-022504-42

• Clinicaltrials.gov Identifier

  NCT01185353

• Research summary

  Research Summary not published at request of researcher

• REC name

  South Central - Oxford A Research Ethics Committee

• REC reference

  11/SC/0142

• Date of REC Opinion

  7 Jun 2011

• REC opinion

  Further Information Favourable Opinion